The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation

PloS One
Yi-Ling WangChungming Chang

Abstract

Hepatitis B virus (HBV) is the smallest DNA virus and the major cause of acute and chronic hepatitis. The 3.2 kb HBV viral genome generates four major species of unspliced viral transcript as well as several alternatively spliced RNAs. A 2.2 kb singly-spliced RNA is the most abundant spliced RNA and is widely expressed among all HBV genotypes. The expression of the singly-spliced RNA, as well as that of its encoded protein HBSP, is strongly associated with hepatopathology during HBV infection. Here, we report a novel inhibitory role of a p21.5 protein, which is encoded by a 2.2 kb singly-spliced RNA, in the modulation of HBV replication. We show that overexpression of the singly-spliced RNA is able to efficiently inhibit HBV replication. Furthermore, a mutation in the ATG start codon of the precore region completely abolishes the inhibitory effect of the singly-spliced RNA, indicating that a viral protein (p21.5) derived from the singly-spliced RNA is the mediator of the inhibition. Furthermore, p21.5 is able to form a homodimer that interacts with core dimers forming hybrid viral assembly components. Sucrose gradient fractionation revealed that co-expression of p21.5 resulted in a spread distribution pattern of core proteins r...Continue Reading

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S Zhou, D N Standring
Feb 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T S SuF K P'eng
Sep 1, 1989·Journal of Virology·T S SuS H Han
Jul 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·O RosmorducD Kremsdorf
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·L V TsuiF V Chisari
Apr 1, 1995·The Journal of General Virology·D CarlierJ M Rossignol
Jan 4, 1998·Journal of Gastroenterology and Hepatology·J R WandsP P Scaglioni
Jan 5, 2000·The Journal of Clinical Investigation·P SoussanD Kremsdorf
Mar 8, 2000·Microbiology and Molecular Biology Reviews : MMBR·C Seeger, W S Mason
Apr 15, 2003·The Journal of General Virology·Parvis AkterAndrew J Davison
Jan 30, 2004·Molecular and Cellular Biology·Gilad Doitsh, Yosef Shaul
Feb 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael D RobekFrancis V Chisari
Jun 12, 2004·Seminars in Liver Disease·Stephen Locarnini
Sep 13, 2005·Biochemical and Biophysical Research Communications·Tsung-Lin ChengWen-Tsan Chang
Jun 7, 2006·Epidemiologic Reviews·Colin W ShepardBeth P Bell
Nov 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Li-Rung HuangDing-Shinn Chen
Jan 9, 2007·World Journal of Gastroenterology : WJG·Thomas F BaumertFritz von Weizsäcker
Jun 6, 2008·The Journal of Infectious Diseases·Patrick SoussanDina Kremsdorf
Mar 7, 2009·The Journal of General Virology·Johanna R AbendMichael J Imperiale

❮ Previous
Next ❯

Citations

Sep 19, 2021·Gut·Dina KremsdorfPatrick Soussan

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
transfection
electrophoresis
enzyme-linked immunosorbent assay
immunoprecipitation
protein folding
ELISA

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.